GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stevanato Group SPA (NYSE:STVN) » Definitions » Price-to-Free-Cash-Flow

Stevanato Group SPA (Stevanato Group SPA) Price-to-Free-Cash-Flow : N/A (As of May. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stevanato Group SPA Price-to-Free-Cash-Flow?

As of today (2024-05-06), Stevanato Group SPA's share price is $26.45. Stevanato Group SPA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.37. Hence, Stevanato Group SPA's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Stevanato Group SPA's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 6 years, Stevanato Group SPA's highest Price-to-Free-Cash-Flow Ratio was 273.78. The lowest was 66.90. And the median was 185.85.

STVN's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.33
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Stevanato Group SPA's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.32. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-1.37.

During the past 6 years, Stevanato Group SPA's highest 3-Year average Free Cash Flow per Share Growth Rate was -68.00% per year. The lowest was -68.00% per year. And the median was -68.00% per year.


Stevanato Group SPA Price-to-Free-Cash-Flow Historical Data

The historical data trend for Stevanato Group SPA's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stevanato Group SPA Price-to-Free-Cash-Flow Chart

Stevanato Group SPA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 249.44 - -

Stevanato Group SPA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Stevanato Group SPA's Price-to-Free-Cash-Flow

For the Medical Instruments & Supplies subindustry, Stevanato Group SPA's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stevanato Group SPA's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stevanato Group SPA's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Stevanato Group SPA's Price-to-Free-Cash-Flow falls into.



Stevanato Group SPA Price-to-Free-Cash-Flow Calculation

Stevanato Group SPA's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=26.45/-1.367
=N/A

Stevanato Group SPA's Share Price of today is $26.45.
Stevanato Group SPA's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Stevanato Group SPA  (NYSE:STVN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Stevanato Group SPA Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Stevanato Group SPA's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Stevanato Group SPA (Stevanato Group SPA) Business Description

Traded in Other Exchanges
Address
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% from South America. It has two segments Biopharmaceutical and Diagnostic Solutions and Engineering.

Stevanato Group SPA (Stevanato Group SPA) Headlines

From GuruFocus